A Phase I Study of MLN6907 in Patients With Metastatic Colorectal
NCT02056015
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Imaging of Solid Gastrointestinal Tumors
Interventions
DRUG:
[68Ga]MLN6907
Sponsor
Millennium Pharmaceuticals, Inc.